On the recordApril 26, 2016
Do not tell me you do not look at it as an investment, because if it costs you money to double the price of a drug and then offer a patient assistance program, you would not be doing it.
Source
congress.govEditor's note · Context
Warren challenges the notion that drug companies don't consider ROI on patient assistance programs.
Share
More from Elizabeth Warren
Jul 18, 2026
If DOD wants to use a PBM, get one that works exclusively for DOD and American taxpayers – and not one that works simultaneously to increase profits for its parent insurance company.
Jul 24, 2026
I believe that tariffs can be used strategically quite valuably, but what the Trump administration is doing is picking the pockets of American consumers.
Jul 16, 2026
The consequences of losing access to your local pharmacy can be immeasurable. Think about veterans with complex medical needs, who rely on the personalized care from their local pharmacist – someone who will check for drug interactions…
Other voices in this conversation
